CONNECT WITH US
HealthTech

HealthTech

#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins

Endpoints News logo

Published on

Add as a preferred source on Google
#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins

Delegates during the cancer vaccine presentation at ESMO in Madrid (Reynald Castaneda for Endpoints News)

Mer­ck and Mod­er­na's can­cer vac­cine da­ta were 'a tri­umph of sci­ence.' And now, the work be­gins

MADRID — In a tes­ta­ment to clin­i­cians’ in­ter­est in Mer­ck and Mod­er­na’s per­son­al­ized can­cer vac­cine da­ta at this year’s Eu­ro­pean So­ci­ety for Med­ical On­col­o­gy con­fer­ence, the …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.